CD38 and acute myeloid leukemia: The CD38 surface marker has been implicated in TNT formation and mitochondrial transfer from MSCs to AML, but also can be leveraged for targeting AML cells for phagocytosis by anti-CD38 antibodies (Farber et al., 2018; Mistry et al., 2019).